Literature DB >> 24367088

Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin.

Oh-Joon Kwon1, Li Zhang, Michael M Ittmann, Li Xin.   

Abstract

Chronic inflammation has been shown to promote the initiation and progression of diverse malignancies by inducing genetic and epigenetic alterations. In this study, we investigate an alternative mechanism through which inflammation promotes the initiation of prostate cancer. Adult murine prostate epithelia are composed predominantly of basal and luminal cells. Previous studies revealed that the two lineages are largely self-sustained when residing in their native microenvironment. To interrogate whether tissue inflammation alters the differentiation program of basal cells, we conducted lineage tracing of basal cells using a K14-CreER;mTmG model in concert with a murine model of prostatitis induced by infection from the uropathogenic bacteria CP9. We show that acute prostatitis causes tissue damage and creates a tissue microenvironment that induces the differentiation of basal cells into luminal cells, an alteration that rarely occurs under normal physiological conditions. Previously we showed that a mouse model with prostate basal cell-specific deletion of Phosphatase and tensin homolog (K14-CreER;Pten(fl/fl)) develops prostate cancer with a long latency, because disease initiation in this model requires and is limited by the differentiation of transformation-resistant basal cells into transformation-competent luminal cells. Here, we show that CP9-induced prostatitis significantly accelerates the initiation of prostatic intraepithelial neoplasia in this model. Our results demonstrate that inflammation results in a tissue microenvironment that alters the normal prostate epithelial cell differentiation program and that through this cellular process inflammation accelerates the initiation of prostate cancer with a basal cell origin.

Entities:  

Keywords:  cells-of-origin for cancer; prostate stem cells

Mesh:

Substances:

Year:  2013        PMID: 24367088      PMCID: PMC3918789          DOI: 10.1073/pnas.1318157111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  64 in total

1.  Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer.

Authors:  L Fong; C L Ruegg; D Brockstedt; E G Engleman; R Laus
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

2.  Acute bacterial inflammation of the mouse prostate.

Authors:  Bayli J Boehm; Sara A Colopy; Travis J Jerde; Christopher J Loftus; Wade Bushman
Journal:  Prostate       Date:  2011-06-16       Impact factor: 4.104

3.  Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model.

Authors:  K E Rippere-Lampe; M Lang; H Ceri; M Olson; H A Lockman; A D O'Brien
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice.

Authors:  G R Cunha; B Lung
Journal:  J Exp Zool       Date:  1978-08

Review 5.  Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities.

Authors:  Nadezda Vashchenko; Per-Anders Abrahamsson
Journal:  Eur Urol       Date:  2005-02       Impact factor: 20.096

6.  The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin.

Authors:  V Vasioukhin; L Degenstein; B Wise; E Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

7.  Notch and TGFβ form a reciprocal positive regulatory loop that suppresses murine prostate basal stem/progenitor cell activity.

Authors:  Joseph M Valdez; Li Zhang; Qingtai Su; Olga Dakhova; Yiqun Zhang; Payam Shahi; David M Spencer; Chad J Creighton; Michael M Ittmann; Li Xin
Journal:  Cell Stem Cell       Date:  2012-11-02       Impact factor: 24.633

8.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

Authors:  Shunyou Wang; Jing Gao; Qunying Lei; Nora Rozengurt; Colin Pritchard; Jing Jiao; George V Thomas; Gang Li; Pradip Roy-Burman; Peter S Nelson; Xin Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

9.  In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme.

Authors:  Li Xin; Hisamitsu Ide; Yoon Kim; Purnima Dubey; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

10.  Association of the innate immunity and inflammation pathway with advanced prostate cancer risk.

Authors:  Rémi Kazma; Joel A Mefford; Iona Cheng; Sarah J Plummer; Albert M Levin; Benjamin A Rybicki; Graham Casey; John S Witte
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more
  99 in total

1.  A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.

Authors:  Nrupen A Bhavsar; Jay H Bream; Alan K Meeker; Charles G Drake; Sarah B Peskoe; Djeneba Dabitao; Angelo M De Marzo; William B Isaacs; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-22       Impact factor: 4.254

2.  Functional evidence that progenitor cells near sites of inflammation are precursors for aggressive prostate cancer.

Authors:  Preston D Crowell; Andrew S Goldstein
Journal:  Mol Cell Oncol       Date:  2017-01-13

3.  Zika Virus Causes Acute and Chronic Prostatitis in Mice and Macaques.

Authors:  Jacques Halabi; Brett W Jagger; Vanessa Salazar; Emma S Winkler; James P White; Peter A Humphrey; Alec J Hirsch; Daniel N Streblow; Michael S Diamond; Kelle Moley
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

Review 4.  The inflammatory microenvironment and microbiome in prostate cancer development.

Authors:  Karen S Sfanos; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Nat Rev Urol       Date:  2017-10-31       Impact factor: 14.432

Review 5.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

6.  Distinct phases of human prostate cancer initiation and progression can be driven by different cell-types.

Authors:  Tanya Stoyanova; Andrew S Goldstein
Journal:  Cancer Cell Microenviron       Date:  2014

7.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

Review 8.  Prostate Luminal Progenitor Cells in Development and Cancer.

Authors:  Dingxiao Zhang; Shuhong Zhao; Xinyun Li; Jason S Kirk; Dean G Tang
Journal:  Trends Cancer       Date:  2018-10-01

Review 9.  Cancer and inflammation.

Authors:  Lance L Munn
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-12-12

Review 10.  Imaging innate immune responses at tumour initiation: new insights from fish and flies.

Authors:  Yi Feng; Paul Martin
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.